An Optimised Monophasic Faecal Extraction Method for LC-MS Analysis and Its Application in Gastrointestinal Disease

Liquid chromatography coupled with mass spectrometry (LC-MS) metabolomic approaches are widely used to investigate underlying pathogenesis of gastrointestinal disease and mechanism of action of treatments. However, there is an unmet requirement to assess faecal metabolite extraction methods for larg...

Full description

Bibliographic Details
Main Authors: Patricia E. Kelly, H Jene Ng, Gillian Farrell, Shona McKirdy, Richard K. Russell, Richard Hansen, Zahra Rattray, Konstantinos Gerasimidis, Nicholas J. W. Rattray
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Metabolites
Subjects:
Online Access:https://www.mdpi.com/2218-1989/12/11/1110
_version_ 1797464591641346048
author Patricia E. Kelly
H Jene Ng
Gillian Farrell
Shona McKirdy
Richard K. Russell
Richard Hansen
Zahra Rattray
Konstantinos Gerasimidis
Nicholas J. W. Rattray
author_facet Patricia E. Kelly
H Jene Ng
Gillian Farrell
Shona McKirdy
Richard K. Russell
Richard Hansen
Zahra Rattray
Konstantinos Gerasimidis
Nicholas J. W. Rattray
author_sort Patricia E. Kelly
collection DOAJ
description Liquid chromatography coupled with mass spectrometry (LC-MS) metabolomic approaches are widely used to investigate underlying pathogenesis of gastrointestinal disease and mechanism of action of treatments. However, there is an unmet requirement to assess faecal metabolite extraction methods for large-scale metabolomics studies. Current methods often rely on biphasic extractions using harmful halogenated solvents, making automation and large-scale studies challenging. The present study reports an optimised monophasic faecal extraction protocol that is suitable for untargeted and targeted LC-MS analyses. The impact of several experimental parameters, including sample weight, extraction solvent, cellular disruption method, and sample-to-solvent ratio, were investigated. It is suggested that a 50 mg freeze-dried faecal sample should be used in a methanol extraction (1:20) using bead beating as the means of cell disruption. This is revealed by a significant increase in number of metabolites detected, improved signal intensity, and wide metabolic coverage given by each of the above extraction parameters. Finally, we addressed the applicability of the method on faecal samples from patients with Crohn’s disease (CD) and coeliac disease (CoD), two distinct chronic gastrointestinal diseases involving metabolic perturbations. Untargeted and targeted metabolomic analysis demonstrated the ability of the developed method to detect and stratify metabolites extracted from patient groups and healthy controls (HC), highlighting characteristic changes in the faecal metabolome according to disease. The method developed is, therefore, suitable for the analysis of patients with gastrointestinal disease and can be used to detect and distinguish differences in the metabolomes of CD, CoD, and HC.
first_indexed 2024-03-09T18:09:22Z
format Article
id doaj.art-e36cef08965b4864b3597bdf30f5dcc2
institution Directory Open Access Journal
issn 2218-1989
language English
last_indexed 2024-03-09T18:09:22Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Metabolites
spelling doaj.art-e36cef08965b4864b3597bdf30f5dcc22023-11-24T09:13:10ZengMDPI AGMetabolites2218-19892022-11-011211111010.3390/metabo12111110An Optimised Monophasic Faecal Extraction Method for LC-MS Analysis and Its Application in Gastrointestinal DiseasePatricia E. Kelly0H Jene Ng1Gillian Farrell2Shona McKirdy3Richard K. Russell4Richard Hansen5Zahra Rattray6Konstantinos Gerasimidis7Nicholas J. W. Rattray8Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of Strathclyde, Glasgow G4 0RE, UKSchool of Medicine, Dentistry & Nursing, University of Glasgow, Glasgow Royal Infirmary, Glasgow G12 8QQ, UKStrathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of Strathclyde, Glasgow G4 0RE, UKBacteria, Immunology, Nutrition, Gastroenterology and Omics (BINGO) Group, University of Glasgow, Glasgow G12 8QQ, UKBacteria, Immunology, Nutrition, Gastroenterology and Omics (BINGO) Group, University of Glasgow, Glasgow G12 8QQ, UKBacteria, Immunology, Nutrition, Gastroenterology and Omics (BINGO) Group, University of Glasgow, Glasgow G12 8QQ, UKStrathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of Strathclyde, Glasgow G4 0RE, UKBacteria, Immunology, Nutrition, Gastroenterology and Omics (BINGO) Group, University of Glasgow, Glasgow G12 8QQ, UKStrathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), University of Strathclyde, Glasgow G4 0RE, UKLiquid chromatography coupled with mass spectrometry (LC-MS) metabolomic approaches are widely used to investigate underlying pathogenesis of gastrointestinal disease and mechanism of action of treatments. However, there is an unmet requirement to assess faecal metabolite extraction methods for large-scale metabolomics studies. Current methods often rely on biphasic extractions using harmful halogenated solvents, making automation and large-scale studies challenging. The present study reports an optimised monophasic faecal extraction protocol that is suitable for untargeted and targeted LC-MS analyses. The impact of several experimental parameters, including sample weight, extraction solvent, cellular disruption method, and sample-to-solvent ratio, were investigated. It is suggested that a 50 mg freeze-dried faecal sample should be used in a methanol extraction (1:20) using bead beating as the means of cell disruption. This is revealed by a significant increase in number of metabolites detected, improved signal intensity, and wide metabolic coverage given by each of the above extraction parameters. Finally, we addressed the applicability of the method on faecal samples from patients with Crohn’s disease (CD) and coeliac disease (CoD), two distinct chronic gastrointestinal diseases involving metabolic perturbations. Untargeted and targeted metabolomic analysis demonstrated the ability of the developed method to detect and stratify metabolites extracted from patient groups and healthy controls (HC), highlighting characteristic changes in the faecal metabolome according to disease. The method developed is, therefore, suitable for the analysis of patients with gastrointestinal disease and can be used to detect and distinguish differences in the metabolomes of CD, CoD, and HC.https://www.mdpi.com/2218-1989/12/11/1110mass spectrometrymetabolite extractioninflammatory bowel diseaseCrohn’s diseasecoeliac disease
spellingShingle Patricia E. Kelly
H Jene Ng
Gillian Farrell
Shona McKirdy
Richard K. Russell
Richard Hansen
Zahra Rattray
Konstantinos Gerasimidis
Nicholas J. W. Rattray
An Optimised Monophasic Faecal Extraction Method for LC-MS Analysis and Its Application in Gastrointestinal Disease
Metabolites
mass spectrometry
metabolite extraction
inflammatory bowel disease
Crohn’s disease
coeliac disease
title An Optimised Monophasic Faecal Extraction Method for LC-MS Analysis and Its Application in Gastrointestinal Disease
title_full An Optimised Monophasic Faecal Extraction Method for LC-MS Analysis and Its Application in Gastrointestinal Disease
title_fullStr An Optimised Monophasic Faecal Extraction Method for LC-MS Analysis and Its Application in Gastrointestinal Disease
title_full_unstemmed An Optimised Monophasic Faecal Extraction Method for LC-MS Analysis and Its Application in Gastrointestinal Disease
title_short An Optimised Monophasic Faecal Extraction Method for LC-MS Analysis and Its Application in Gastrointestinal Disease
title_sort optimised monophasic faecal extraction method for lc ms analysis and its application in gastrointestinal disease
topic mass spectrometry
metabolite extraction
inflammatory bowel disease
Crohn’s disease
coeliac disease
url https://www.mdpi.com/2218-1989/12/11/1110
work_keys_str_mv AT patriciaekelly anoptimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease
AT hjeneng anoptimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease
AT gillianfarrell anoptimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease
AT shonamckirdy anoptimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease
AT richardkrussell anoptimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease
AT richardhansen anoptimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease
AT zahrarattray anoptimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease
AT konstantinosgerasimidis anoptimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease
AT nicholasjwrattray anoptimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease
AT patriciaekelly optimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease
AT hjeneng optimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease
AT gillianfarrell optimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease
AT shonamckirdy optimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease
AT richardkrussell optimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease
AT richardhansen optimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease
AT zahrarattray optimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease
AT konstantinosgerasimidis optimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease
AT nicholasjwrattray optimisedmonophasicfaecalextractionmethodforlcmsanalysisanditsapplicationingastrointestinaldisease